PremiumCompany AnnouncementsImmuPharma Advances in Autoimmune Disease Research Amid Share Price Fluctuations ImmuPharma Unveils Breakthrough in Autoimmune Disease Research ImmuPharma Targets Global Partnerships at Key Biotech Events PremiumCompany AnnouncementsImmuPharma Appoints New Company Secretary for Strategic Growth ImmuPharma Extends Incanthera Warrants to 2025 ImmuPharma Shows Strong Progress and Reduced Losses PremiumCompany AnnouncementsImmuPharma Realizes £1.5 Million from Share Sale ImmuPharma Major Shareholding Shift Noted ImmuPharma Showcases Potential at BIO-Equity 2024